Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s): LBLTF

Healthcare Biotechnology

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.

TSXV:LBL.H - Post by User

Lattice Biologics Ltd > What do we know for CERTAIN ??

<< Previous

Bullboard Posts

Next >>

Comment by DigitalSpurson Apr 20, 2020 12:30pm

123 Views

Post# 30930203

RE:What do we know for CERTAIN ??

Employee stock option pricing went from 7.5c to 9.5c (a 26% increase).

Stem cells from this company do not harm anyone.

Studies being conducted already in the states; this company is doing studies in three different countries.

They don't throw out news for a small change - only massive news is released - no real volume, so no selling - everyone is holding on for dear life here, including insiders and execs.

Already has FDA approval for their stem cell process, hence studies already about to begin in the states - no hurdles from FDA for them at all. Other companies still need to synthesize drugs or show efficacy - not LBL - they are already in the game for emryotic stem cell recovery

Lots more, but please do your own dilligence on the board. This is a gem and I'm not selling for sometime!!

<< Previous

Bullboard Posts

Next >>

'Coin Stories' host Natalie Brunell shares Bitcoin basics and tips